In vitro experiments have shown that knockdown SECTM1 expression can significantly inhibit the proliferation, invasion and migration of glioma cells, and in vivo experiments have proved that SECTM1 low expression has an inhibitory effect on the growth of glioma. This evidence concerns the gene SECTM1 and central nervous system cancer.